At the closing, the new governance structure of Città di Roma was defined, with the appointment of the following Directors and Auditors:
Mr. Mariano Garofalo (Chairman);
Mrs. Maria Laura Garofalo (Director);
Mrs. Claudia Garofalo (Director);
Mr. Piergiuseppe Bagnera (Single Auditor).
The new General Manager of the facility, Mrs. Raffaella Ferradini, was also introduced, professional with 13 years of experience in the management and organization of companies operating in the accredited private healthcare sector. She is also competent in administrative accounting processes, thanks to her decennial experience as a senior manager specialized in auditing and consulting at a leading company in the industry.
The new governance will facilitate the timely implementation of a major reorganization plan for the activities provided by the various facilities, the first phase of which will involve, already since spring 2026, the effective repositioning of Casa di Cura Città di Roma and European Hospital facilities. More specifically, this will involve the reorganization and reallocation of the individual departments of the two facilities, allowing each facility to focus on unique and distinctive areas while avoiding duplication of activities and, consequently, costs. Casa di Cura Città di Roma will become a post-acute care facility with 80 dependency care beds and 52 rehabilitation beds, as well as two hemodialysis rooms and a specialist outpatient center that will operate under both accredited and private regimes.
Overall, as a result of the acquisition the GHC Group will strengthen its competitive position in the Lazio Region, qualifying itself as an integrated operator capable of covering all the main healthcare and social assistance needs of the territory in an effective and efficient manner.
The Equity Value of the transaction is €15.2M, substantially lower than just the value of the Real Estate assets of the Target, with a total area of approx. 8,000sqm.
The Enterprise Value is equal to approximately €20.7M.
The acquisition has been financed through own resources and with recourse to bank financing, as GHC has the availability of a Capex Line for new acquisitions granted to the Group in 2024 by a pool of leading national and international financial institutions (UniCredit, Banco BPM, BNL BNP Paribas, Monte dei Paschi di Siena, Cassa Depositi e Prestiti).
Please note that the acquisition is classified as a transaction with related parties of lesser significance. For further information, please refer to the press release dated July 18, 2025.
* * *
The GHC GroupThe GHC Group, listed on the Euronext STAR segment of the Italian Stock Exchange, is an Italian accredited private healthcare leader operating through 38 healthcare clinics demonstrating excellence and offering a comprehensive range of services covering all areas of healthcare thanks to diversified specialties, the use of cutting-edge technologies and highly-qualified personnel. The Group in fact operates across eight regions in Northern and Central Italy (Piedmont, Lombardy, Veneto, Friuli-Venezia Giulia, Emilia Romagna, Liguria, Tuscany and Lazio), covering in the hospital sector acute admissions, long-term care, post-acute rehabilitations and outpatient services (the "Hospital Sector"), and in the social services and dependency care sector covering residential admissions and district outpatient services (the "Community Care and Dependency Care Sector").
* * *
FOR FURTHER DETAILS:Garofalo Health Care S.p.A. Mimmo Nesi - Investor Relator
Tel. +39 06 68489231 - ir@garofalohealthcare.com Website: https://www.garofalohealthcare.com
Press OfficeBarabino & Partners
Massimiliano Parboni - m.parboni@barabino.it Tel. +39 335 8304078
Giuseppe Fresa - g.fresa@barabino.it Tel. +39 348 5703197